Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

Direct‐acting antiviral therapies (DAAs) may improve kidney function and proteinuria in certain patients with hepatitis C infection (HCV) and chronic kidney disease (CKD). To improve our understanding of HCV‐mediated kidney dysfunction, we aimed to evaluate the baseline predictors of improvement in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hepatol Commun
Hlavní autoři: Sise, Meghan E., Strohbehn, Ian, Chute, Donald, Corey, Kathleen E., Fusco, Dahlene N., Sabbisetti, Venkata S, Waikar, Sushrut S., Chung, Raymond T.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7395066/
https://ncbi.nlm.nih.gov/pubmed/32766479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1528
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky